Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Independently Tested Each batch is independently tested to ensure product purity and dosage
Given the disappointing result for the once-daily version, shares of MapLight fell by more than 60 percent on Monday following the announcement, as it means that the drug is unlikely to out compete Bristol Myers Squibbs twice-daily oral Cobenfy approved in 2024
A.ElnourR
Clear dose-response from 0.3 mg to 4.5 mg
Extracellular matrix degradation and remodeling in development and disease
Adding 2 mL yields 2.5 mg/mL
US$ 27.88
US$ 24.52
US$ 21.28
US$ 22.58
US$ 26.35
US$ 27.80
